Advertisement
Screener

SUPERNUS PHARMACEUTICALS, INC. (SUPN) Total Contract Liability

2.8 / 5 stars · 68/120 Roast Me

SUPERNUS PHARMACEUTICALS, INC. Total Contract Liability

SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Total Contract Liability of $3.10 million as of 2025-12-31, per its 10-K filed 2026-03-02.

Financial Statements › Balance Sheet › Liabilities

us-gaap:ContractWithCustomerLiability · last filed 2026-03-02

  • 2025-12-31: Contract with Customer, Liability $3.10M.
  • 2025-09-30: Contract with Customer, Liability $0.00.
  • 2024-12-31: Contract with Customer, Liability $0.00.
  • 2023-12-31: Contract with Customer, Liability $0.00.
Period endContract with Customer, Liability
2025-12-31$3.10M
10-K · filed 2026-03-02
2025-09-30$0.00
10-Q · filed 2025-11-06
2024-12-31$0.00
10-K · filed 2026-03-02
2023-12-31$0.00
10-K · filed 2025-02-25
2022-12-31$0.00
10-K · filed 2023-03-09
2021-12-31$0.00
10-K · filed 2023-03-09
2020-12-31$0.00
10-K · filed 2022-04-13
2019-12-31$0.00
10-K · filed 2021-03-08
2019-09-30$0.00
10-Q · filed 2019-11-08
2019-06-30$0.00
10-Q · filed 2019-08-09
2019-03-31$0.00
10-Q · filed 2019-05-10
2018-12-31$0.00
10-K · filed 2020-02-28
2018-09-30$0.00
10-Q · filed 2018-11-09
2018-06-30$0.00
10-Q · filed 2018-08-09
2018-03-31$0.00
10-Q · filed 2018-05-10
2018-01-01$0.00
10-K · filed 2019-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38